Clinical trial
Comparison of Intralase and Visumax Femtosecond Laser for Laser In Situ Keratomileusis
NCT01252654 is registered in ClinicalTrials.gov with Singapore Eye Research Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Comparison of Intralase and Visumax Femtosecond Laser for Laser In Situ Keratomileusis
- Lead sponsor
- Singapore Eye Research Institute
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 31, 2010
- Completion date
- August 31, 2013
- Enrollment
- 120 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.